Cite
Polypharmacy and potentially-inappropriate medications are prevalent in the elderly cancer patients receiving systemic cancer therapy and they co-relate with adverse outcomes.
MLA
Bandidwattanawong, Chanyoot, et al. “Polypharmacy and Potentially-Inappropriate Medications Are Prevalent in the Elderly Cancer Patients Receiving Systemic Cancer Therapy and They Co-Relate with Adverse Outcomes.” BMC Geriatrics, vol. 23, no. 1, Nov. 2023, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12877-023-04471-3.
APA
Bandidwattanawong, C., Rattanaserikulchai, P., & Jetsadavanit, N. (2023). Polypharmacy and potentially-inappropriate medications are prevalent in the elderly cancer patients receiving systemic cancer therapy and they co-relate with adverse outcomes. BMC Geriatrics, 23(1), 1–11. https://doi.org/10.1186/s12877-023-04471-3
Chicago
Bandidwattanawong, Chanyoot, Pat Rattanaserikulchai, and Nontakorn Jetsadavanit. 2023. “Polypharmacy and Potentially-Inappropriate Medications Are Prevalent in the Elderly Cancer Patients Receiving Systemic Cancer Therapy and They Co-Relate with Adverse Outcomes.” BMC Geriatrics 23 (1): 1–11. doi:10.1186/s12877-023-04471-3.